meloxicam potassium salt monohydrate
meloxicam
Conditions | Yield |
---|---|
Stage #1: meloxicam potassium salt monohydrate With potassium hydroxide; pyrographite In ethanol; water at 40 - 45℃; for 0.666667h; Stage #2: With acetic acid In ethanol; water at 10 - 30℃; for 2.5h; pH=3 - 5; Product distribution / selectivity; | 98.5% |
Stage #1: meloxicam potassium salt monohydrate With potassium hydroxide; pyrographite In ethanol; water at 40 - 45℃; for 0.666667h; Stage #2: With hydrogenchloride In ethanol; water at 10 - 30℃; for 2.5h; pH=3 - 5; Product distribution / selectivity; | 97.1% |
Stage #1: meloxicam potassium salt monohydrate With potassium hydroxide In ethanol; water at 50 - 55℃; Large scale reaction; Stage #2: With hydrogenchloride In ethanol; water at 65 - 70℃; Reflux; Large scale reaction; | 91% |
5-methyl-2-thiazol-2-amine
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
meloxicam
Conditions | Yield |
---|---|
In o-xylene for 24h; Product distribution / selectivity; Heating / reflux; | 95% |
In xylene at 139 - 140℃; for 32 - 37h; Product distribution / selectivity; Heating / reflux; Molecular sieve; | 92.48% |
5-methyl-2-thiazol-2-amine
methyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
meloxicam
Conditions | Yield |
---|---|
In o-xylene at 25 - 145℃; for 33.5 - 38h; Industry scale; | 88.8% |
In xylene for 48h; Heating; |
N-methylglucamine salt of meloxicam
meloxicam
Conditions | Yield |
---|---|
Stage #1: N-methylglucamine salt of meloxicam In water at 70℃; for 0.5h; CN1 carbon; Stage #2: With water; acetic acid at 70℃; for 0.25h; pH=4.6; Product distribution / selectivity; | 87% |
5-methyl-2-thiazol-2-amine
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
1,2-dichloro-benzene
meloxicam
Conditions | Yield |
---|---|
With 1,2-dichloro-ethane | 76% |
5-methyl-2-thiazol-2-amine
4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide
meloxicam
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid; 1,2-dichloro-ethane | 48% |
methyl 3-oxo-2,3-dihydrobenzo[d][1,2]thiazol-2-acetate 1,1-dioxide
meloxicam
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 25percent MeONa/MeOH / toluene / 4 h / 80 °C 2: 1M aq.NaOH / ethanol / 24 h / Ambient temperature 3: xylene / 48 h / Heating View Scheme |
methyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
meloxicam
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 1M aq.NaOH / ethanol / 24 h / Ambient temperature 2: xylene / 48 h / Heating View Scheme |
saccharin
meloxicam
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: 1.) NaH / 1.) DMF, 50 deg C, 30 min, 2.) DMF, 4 h 2: 25percent MeONa/MeOH / toluene / 4 h / 80 °C 3: 1M aq.NaOH / ethanol / 24 h / Ambient temperature 4: xylene / 48 h / Heating View Scheme |
5-methyl-2-thiazol-2-amine
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
B
meloxicam
Conditions | Yield |
---|---|
In xylene at 139 - 140℃; for 32 - 37h; |
meloxicam
Conditions | Yield |
---|---|
Stage #1: With sodium methylate In methanol for 0.166667h; Stage #2: With pyrographite In methanol Stage #3: With hydrogenchloride In methanol; water pH=1.12 - 3.70; Purification / work up; |
meloxicam
Conditions | Yield |
---|---|
Stage #1: With sodium methylate In methanol for 0.166667h; Stage #2: With pyrographite In methanol Stage #3: With hydrogenchloride In methanol; water pH=2.3 - 2.4; Purification / work up; |
5-methyl-2-thiazol-2-amine
methyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
A
methanol
C
meloxicam
Conditions | Yield |
---|---|
pyrographite In xylene at 170 - 180℃; for 24h; Product distribution / selectivity; |
5-methyl-2-thiazol-2-amine
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
A
methanol
C
meloxicam
Conditions | Yield |
---|---|
pyrographite In xylene at 170 - 180℃; for 24h; Product distribution / selectivity; |
5-methyl-2-thiazol-2-amine
methyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
A
N-[3,5-dimethyl-1,3-thiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
B
meloxicam
Conditions | Yield |
---|---|
With methane In 5,5-dimethyl-1,3-cyclohexadiene at 138 - 142℃; for 24h; Inert atmosphere; Large scale reaction; |
ethene
meloxicam
Conditions | Yield |
---|---|
In 5,5-dimethyl-1,3-cyclohexadiene; [(2)H6]acetone |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; |
Conditions | Yield |
---|---|
In chloroform for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; |
meloxicam
maleic acid
4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide maleic acid (1:1)
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; | |
In ethyl acetate for 19h; Solvent; | |
In tetrahydrofuran at 20℃; for 24h; |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; | |
Stage #1: meloxicam; benzoic acid for 0.25h; Milling; Stage #2: In acetone | |
In tetrahydrofuran at 20℃; for 0.5h; Solvent; Milling; |
Conditions | Yield |
---|---|
In chloroform for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; |
succinic acid
meloxicam
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; | |
Stage #1: succinic acid; meloxicam for 0.25h; Milling; Stage #2: In acetone Solvent; | |
In ethyl acetate at 30℃; Solvent; |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; | |
Stage #1: Adipic acid; meloxicam for 0.25h; Milling; Stage #2: In acetone Solvent; |
Conditions | Yield |
---|---|
for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; |
meloxicam
salicylic acid
4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide salicylic acid (1:1)
Conditions | Yield |
---|---|
In ethyl acetate for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; | |
Stage #1: meloxicam; salicylic acid for 0.25h; Milling; Stage #2: In acetone |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran |
meloxicam
1-hydroxy-2-naphthoic acid
4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide 1-hydroxy-2-naphthoic acid (1:1)
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
In tetrahydrofuran Product distribution / selectivity; | |
In dimethylsulfoxide-d6; water at 25 - 90℃; Solvent; | 71 g |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
Conditions | Yield |
---|---|
In tetrahydrofuran for 0.5h; | 100% |
1-deoxy-1-(methylamino)-D-glucitol
meloxicam
N-methylglucamine salt of meloxicam
Conditions | Yield |
---|---|
In ethanol at 60℃; for 0.5h; | 93% |
meloxicam
Conditions | Yield |
---|---|
With acetic acid | 92% |
Conditions | Yield |
---|---|
In chloroform at 20℃; | 91% |
In tetrahydrofuran Product distribution / selectivity; |
methyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
meloxicam
5-methyl-2-thiazol-2-amine
Conditions | Yield |
---|---|
With montmorillonite MK10 impregnated with ZnCl2 In o-xylene for 24h; Reagent/catalyst; Reflux; Green chemistry; | 90% |
meloxicam
Conditions | Yield |
---|---|
In methanol N2, mixed a hot solns., refluxed for 0.5 h; ppt. filtered, washed (hot methanol under N2), dried (vac., room temp.);elem. anal.; | 88% |
meloxicam
Conditions | Yield |
---|---|
In dichloromethane at 20℃; for 12h; Inert atmosphere; | 81% |
Conditions | Yield |
---|---|
for 2h; Reflux; | 80% |
[ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2
meloxicam
Conditions | Yield |
---|---|
In dichloromethane at 20℃; for 12h; Inert atmosphere; | 80% |
Conditions | Yield |
---|---|
In ethanol for 24h; Reflux; | 79% |
di-μ-bromo-bis[bromo(η(6)-para-cymene)ruthenium(II)]
meloxicam
Conditions | Yield |
---|---|
Stage #1: meloxicam With sodium methylate In methanol at 20℃; for 0.5h; Stage #2: di-μ-bromo-bis[bromo(η(6)-para-cymene)ruthenium(II)] In methanol at 20℃; for 4h; | 79% |
In Europe, where the product has been available since the early 1990s, it is also prescribed and licensed for other anti-inflammatory benefits including relief from both acute and chronic pain in dogs and cats. For many years, both injectable and oral (liquid and tablet) formulations of meloxicam have been licensed for use in dogs, and injectable ones for use in cats. In June 2007, a new oral version of Metacam was licensed in Europe for the long-term relief of pain in cats. As of June 2008, Meloxicam is registered for long term use in cats in Australia, New Zealand, and throughout Europe. 'Metacam oral suspension 1.5 is not approved or recommended (according to the manufacture insert) for use in cats in the U.S.
The IUPAC name of Meloxicam is (3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1λ6,2-benzothiazin-4-one. With the CAS registry number 71125-38-7, it is also named as 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methylthiazolyl)-, 1,1-dioxide. The product's categories are Active Pharmaceutical Ingredients; API; Health & Beauty; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds; API's; Lipid Signaling, and the other registry number is 133687-22-6. Besides, it is light yellow solid, which should be stored in sealed containers in a cool, dry place away from oxidizing agents at 0-6 °C. In addition, its molecular formula is C14H13N3O4S2 and molecular weight is 351.40.
The other characteristics of this product can be summarized as: (1)ACD/LogP: 2.66; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2; (4)ACD/LogD (pH 7.4): 0; (5)ACD/BCF (pH 5.5): 6; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 64; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 7; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 136.22 Å2; (13)Index of Refraction: 1.72; (14)Molar Refractivity: 85.956 cm3; (15)Molar Volume: 217.724 cm3; (16)Polarizability: 34.076×10-24cm3; (17)Surface Tension: 85.325 dyne/cm; (18)Density: 1.614 g/cm3; (19)Melting Point: 255 °C; (20)Water Solubility: 7.150 mg/L at 25 °C.
Preparation of Meloxicam: this chemical can be prepared by Methyl 4-hydroxy-2-methyl-(2H)-1,2-benzothiazine-3-carboxylate-1,1-dioxide and 2-Amino-5-methylthiazole. The yield is 74 %.
Uses of Meloxicam: this chemical is a nonsteroidal anti-inflammatory drug with analgesic and fever reducer effects. And it inhibits cyclooxygenase that can be used as an anti-inflammatory. Additionally, it can be used for the treatment of rheumatoid arthritis and osteoarthritis.
When you are using this chemical, please be cautious about it as the following: it irritates to eyes, respiratory system and skin. And it is harmful if swallowed. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice.
People can use the following data to convert to the molecule structure.
(1)SMILES: Cc1cnc(s1)NC(=O)C\3=C(/O)c2ccccc2S(=O)(=O)N/3C
(2)InChI: InChI=1/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)
(3)InChIKey: ZRVUJXDFFKFLMG-UHFFFAOYAR
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View